Howard Dittrich, M.D.

Chief Medical Officer

Dr. Dittrich has over 20 years of experience as a cardiologist and therapeutic research and clinical development executive.

He previously served as chief medical officer at Laguna Pharmaceuticals, Sorbent Therapeutics, Sequel Pharmaceuticals and NovaCardia. Prior to NovaCardia, he held executive positions at Molecular Biosystems and Alliance Pharmaceutical. In these positions, he oversaw clinical development and regulatory affairs and was instrumental in gaining FDA approval of two cardiovascular imaging agents.

Howard is an adjunct professor of medicine and chair of the board of directors of the François M. Abboud Cardiovascular Research Center at the University of Iowa Carver College of Medicine. He was previously a faculty member of the department of medicine and a clinical professor of medicine at the University of California, San Diego (UCSD).  Dr. Dittrich is also an entrepreneur-in-residence on the Frazier Healthcare Partners Life Sciences team.

Dr. Dittrich holds a B.S. from the University of Iowa and an M.D. from the University of Iowa Carver College of Medicine. He completed his residency in internal medicine and clinical fellowship in cardiology at UCSD.